why choose us

Clinical Trials Search

Showing 9,640 of 132,963 result(s)
InsightPFA Trial of the LotosPFA Catheter

Status: COMPLETED

Condition: Arrhythmias, Cardiac

Interventions: In the test group, subjects will undertake PVI using the PFA system including a nanosecond-scale pulsed field generator (InRythm, Insight Lifetech, Sh

Date: 2023-08-07

Diagnostic and Translational Values of Point-of-care Blood Eosinophils and Exhaled Nitric Oxide (FeNO) in People Referred by Primary Care for Suspected Asthma

Status: COMPLETED

Condition: Asthma

Interventions: FeNO measured with a NIOX VERO device after the methacholine challenge

Date: 2023-08-07

Impact of Adding Cognitive Behaviour Therapy to Supervised Pilates-based Core Stability Training in Patients With Multiple Sclerosis

Status: COMPLETED

Condition: Multiple Sclerosis

Interventions: Exercises were structured in different conditions such as supine, side-lying, prone, quadruped, sitting, and standing positions.
The various vari

Date: 2023-08-07

A Study of Efficacy, Safety, and Tolerability of KAN-101 in People with Celiac Disease

Status: COMPLETED

Condition: Celiac Disease

Interventions: Dose KAN-101 Intravenous (IV) Infusion

Date: 2023-08-07

Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1403 and mRNA-1405 to Prevent Norovirus Acute Gastroenteritis in Healthy Adults 18 to 80 Years of Age

Status: COMPLETED

Condition: Norovirus Acute Gastroenteritis

Interventions: BIOLOGICAL: mRNA-1403 - Sterile liquid for injection
BIOLOGICAL: mRNA-1405 - Sterile liquid for injection
BIOLOGICAL: Placebo - 0.9% sodium

Date: 2023-08-07

CogT pSOPT Intervention Study

Status: Completed

Condition: Mild Cognitive Impairment

Interventions: computerized cognitive training practicing speed of processing, the difficulty will be adjusted based on real-time monitored RMSSD (parasympathetic ne

Date: 2023-08-07

Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed;Refractory Acute Myeloid Leukemia

Status: Completed

Condition: AML

Interventions: Oral administration

Date: 2023-08-07

A Study of Loco-Regional Liposomal Bupivacaine Injection

Status: Completed

Condition: Peripheral Arterial Disease

Interventions: Injection into pelvic area and into the edges of wound at the end of the procedure.

Date: 2023-08-07

A Study of PER-001 in Participants With Diabetic Retinopathy

Status: Completed

Condition: Diabetic Retinopathy

Interventions: PER-001 Low Dose Intravitreal Implant

Date: 2023-08-07